E
Athira Pharma, Inc. ATHA
$0.36 $0.01885.51% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -18.87% -11.00% -3.42% -41.41% -23.90%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -65.56% -49.20% -27.25% -11.42% -7.00%
Operating Income 65.56% 49.20% 27.25% 11.42% 7.00%
Income Before Tax 65.28% 45.01% 12.83% 9.25% 5.33%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 65.28% 45.01% 12.83% 9.25% 5.33%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 65.28% 45.01% 12.83% 9.25% 5.33%
EBIT 65.56% 49.20% 27.25% 11.42% 7.00%
EBITDA 66.14% 49.59% 27.44% 11.50% 7.07%
EPS Basic 65.92% 45.87% 13.87% 10.16% 6.31%
Normalized Basic EPS 66.03% 49.32% 26.24% 10.15% 6.47%
EPS Diluted 65.92% 45.87% 13.87% 10.16% 6.31%
Normalized Diluted EPS 66.03% 49.32% 26.24% 10.15% 6.47%
Average Basic Shares Outstanding 1.88% 1.58% 1.22% 1.00% 1.05%
Average Diluted Shares Outstanding 1.88% 1.58% 1.22% 1.00% 1.05%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --